RecruitingNot Applicable

Cultural Adaptation of Drug Treatment for DJJ Youth

United States55 participantsStarted 2024-05-15

Plain-language summary

This project aims to improve the understanding of the impact of Ethnic and Racial Discrimination (ERD) on adolescent alcohol and other drug use (AOD) within the Black Justice-Involved Youth (JIY) population. Individual interviews with Black JIY and focus groups with parents and guardians of Black JIY and community members who support change and reform in the justice community for Black JIY will be conducted.

Who can participate

Age range

13 Years – 17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

For Focus Groups and Interviews: Black JIY Participants: Inclusion Criteria: • 1) Between the ages of 13-17; 2) identify as Black or African American; and 3) on community probation. Exclusion Criteria: • Will be excluded if they do not have parental consent to participate. For Focus Groups and Interviews: Adult Participants Inclusion Criteria: * A guardian of JIY * An advocate (someone who supports change and reform in the justice community) for Black JIY. Exclusion Criteria: • Will be excluded if they do not provide consent to participate. For pilot feasibility study: Black JIY Participants: Inclusion Criteria: * Between the ages of 13 and 17 * Identify as Black or African American * Be on community probation * Meet criteria for alcohol, cannabis, or other drug misuse as defined by the DSM 5 * Be experiencing at least 1 problem related to AOD; * The frequency of AOD must be weekly use over a 3-month period Exclusion Criteria: * Will be excluded if they do not have parental consent to participate * Parole violation

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Feasibility and Acceptability

Timeframe: After study completion, an average of 3 months

Trial details

NCT IDNCT06003725

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-04-30

Contact for this trial

Brittany E Bryant, DSW

843-973-0867 brittany.bryant@ucsf.edu

View on ClinicalTrials.gov More Substance Use trials